TBPH Theravance Biopharma

Theravance Biopharma earnings company data as of 4:49 AM ET 9/24

Scheduled

1 period · newest first · EPS & Rev stacked · nothing reported yet

Period	Date	Metric	Estimate	Actual	Result
FY2026 Q3	9 Nov	EPS	0.19	—	—
FY2026 Q3	9 Nov	Rev	—	—	—

Recent issuer filings from EDGAR · 11 shown · open Filing / Doc on SEC.gov

Filed	Form	Detail	Links
Sep 23, 2026	8-K	1.01,2.01,3.01,3.03,5.01,5.02,5.03,8.01,9.01	Filing Doc
Sep 18, 2026	8-K	5.07	Filing Doc
Sep 10, 2026	8-K	8.01	Filing Doc
Aug 25, 2026	8-K	8.01,9.01	Filing Doc
Aug 25, 2026	DEFA14A		Filing Doc
Aug 11, 2026	10-Q		Filing Doc
Aug 10, 2026	8-K	2.02,9.01	Filing Doc
Jun 29, 2026	8-K	1.01,7.01,8.01,9.01	Filing Doc
Jun 29, 2026	DEFA14A		Filing Doc
Jun 23, 2026	8-K	5.02	Filing Doc
Jun 12, 2026	8-K	5.07	Filing Doc

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed	Form	Detail	Links
Sep 28, 2026	4	Period Sep 23, 2026	Filing Doc
Sep 24, 2026	4	Period Sep 23, 2026 · 4 forms	Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

Consensus estimates · SEC filings remain the official record · not investment advice